Twenty-five years after one of the authors found the first p53 mutation in a primary medulloblastoma [7], when others were able to detect similar mutations in cell lines, but not in primary medulloblastomas [12], molecular diagnostics became a state-of-the-art method in tissue biopsies of brain tumors. Here, TP53 is linked to medulloblastoma.